Difficulty: Medium
Average Score: 74%
Practice
A patient who sustained a myocardial infarction comes to the clinic for a refill of atorvastatin (Lipitor). The family nurse practitioner explains that the medication is prescribed for:
Correct answer
C
Rationale
In this scenario, the correct answer is C) secondary prevention. Atorvastatin (Lipitor) is a statin medication used to lower cholesterol levels. In the context of a patient who has had a myocardial infarction (heart attack), atorvastatin is prescribed for secondary prevention. Secondary prevention aims to prevent further complications and events in individuals who already have a known disease or condition, such as a heart attack. By lowering cholesterol levels, atorvastatin helps reduce the risk of future cardiovascular events.
Option A) cancer prevention is incorrect because atorvastatin is not primarily prescribed for preventing cancer. Its primary indication is in managing cholesterol levels and preventing cardiovascular events.
Option B) primary prevention is also incorrect as this phase focuses on preventing the initial occurrence of a disease or condition in individuals without it. Atorvastatin is not typically used in individuals without a history of cardiovascular events.
Option D) tertiary prevention involves managing the long-term consequences of a condition to prevent further complications. Atorvastatin use in this context would be more aligned with secondary prevention, focusing on reducing the risk of recurrent cardiovascular events rather than managing chronic complications.
Educationally, understanding the principles of primary, secondary, and tertiary prevention is crucial for healthcare providers to appropriately manage patient care and tailor interventions based on individual patient needs and health conditions. By grasping these concepts, nurse practitioners can effectively communicate treatment plans and rationale to patients, ensuring optimal outcomes and preventive care strategies are implemented.
Option A) cancer prevention is incorrect because atorvastatin is not primarily prescribed for preventing cancer. Its primary indication is in managing cholesterol levels and preventing cardiovascular events.
Option B) primary prevention is also incorrect as this phase focuses on preventing the initial occurrence of a disease or condition in individuals without it. Atorvastatin is not typically used in individuals without a history of cardiovascular events.
Option D) tertiary prevention involves managing the long-term consequences of a condition to prevent further complications. Atorvastatin use in this context would be more aligned with secondary prevention, focusing on reducing the risk of recurrent cardiovascular events rather than managing chronic complications.
Educationally, understanding the principles of primary, secondary, and tertiary prevention is crucial for healthcare providers to appropriately manage patient care and tailor interventions based on individual patient needs and health conditions. By grasping these concepts, nurse practitioners can effectively communicate treatment plans and rationale to patients, ensuring optimal outcomes and preventive care strategies are implemented.